Transvaginal radio frequency treatment fails in second test.(Gynecology)

ATLANTA -- The promising results seen in initial studies of SURx transvaginal radio frequency for the treatment of stress urinary incontinence were not replicated in a recent series of patients.

"We were unable to replicate previously reported response with the SURx procedure despite adequate technique, and although we found it to be safe, we have decided not to continue to offer this as a treatment option for our patients," Dr. Gunhilde Buchsbaum said at the annual meeting of the American Urogynecologic Society.

Initial studies of the SURx system, which was approved for use in the United States in 1997, showed cure rates and patient satisfaction rates in the 80% range. In the current study comprising 15 patients treated at the University of Rochester (N.Y.) Medical Center from January 2003 to April 2004, the success rate was low, patient satisfaction was low, and the rate of additional treatment was high, said Dr. Buchsbaum of the departments of obstetrics and gynecology, and urology at the university.

Before treatment, all patients had a mean Valsalva leak-point pressure (VLPP) of 150 cm [H.sub.2]O, and seven had ...